Arboretum_JD, Author at Arboretum Ventures

EQRx News Page

EQRx Reports Second Quarter 2022 Financial Results and Recent Corporate Progress

EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative…

Arboretum_JDAugust 11, 2022

Pear Therapeutics to Be Added to Russell US Index Series

Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription…

Arboretum_JDAugust 3, 2022

Flosonics Medical Home Page News Page

FloPatch featured in Frontiers in Medical Technology’s Highlights in Diagnostic and Therapeutic Devices

Flosonics Medical is pleased to announce that its recent publication with Frontiers in Medical Technology…

Arboretum_JDJuly 27, 2022

Avation Medical Home Page News Page

Avation Medical CEO Selected as Top 25 Women Leaders in Consumer HealthTech of 2022

The Healthcare Technology Report is pleased to announce The Top 25 Women Leaders in Consumer…

Arboretum_JDJuly 14, 2022

Convergent Dental News Page

Convergent Dental Announces Retirement of Founder-CEO

Convergent Dental, Inc. recently announced the retirement of Mike Cataldo, founder-CEO. Robert L. Gershon will…

Arboretum_JDJune 30, 2022

Akadeum News Page

Akadeum Life Sciences Granted Transformative Patent for Buoyancy-Based Cell Separation “Microbubble” Technology

Akadeum Life Sciences, Inc., a global leader in buoyancy-based technology in cell therapy manufacturing, clinical…

Arboretum_JDJune 21, 2022

Health Scholars News Page

NYC Health + Hospitals Debuts Obstetrics Virtual Reality Technology as Part of its Ongoing, Comprehensive Maternal Health Simulation Trainings

NYC Health + Hospitals and Health Scholars recently announced the introduction of new virtual reality (VR) technology…

Arboretum_JDJune 20, 2022

Health Scholars News Page

Relias Partners With Health Scholars, Leading Healthcare Virtual Reality Company, to Improve OB Provider Care

Relias, trusted partner to more than 11,000 healthcare organizations and 4.5 million caregivers, announced today…

Arboretum_JDJune 15, 2022

EQRx News Page

EQRx Announces Acceptance of Market Authorization Application by the UK’s MHRA

EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative…

Arboretum_JDJune 14, 2022

EQRx News Page

EQRx Announces New Data for Lead Oncology Programs

EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative…

Arboretum_JDMay 27, 2022

Arboretum_JD

EQRx Reports Second Quarter 2022 Financial Results and Recent Corporate Progress

Pear Therapeutics to Be Added to Russell US Index Series

FloPatch featured in Frontiers in Medical Technology’s Highlights in Diagnostic and Therapeutic Devices

Avation Medical CEO Selected as Top 25 Women Leaders in Consumer HealthTech of 2022

Convergent Dental Announces Retirement of Founder-CEO

Akadeum Life Sciences Granted Transformative Patent for Buoyancy-Based Cell Separation “Microbubble” Technology

NYC Health + Hospitals Debuts Obstetrics Virtual Reality Technology as Part of its Ongoing, Comprehensive Maternal Health Simulation Trainings

Relias Partners With Health Scholars, Leading Healthcare Virtual Reality Company, to Improve OB Provider Care

EQRx Announces Acceptance of Market Authorization Application by the UK’s MHRA

EQRx Announces New Data for Lead Oncology Programs

News & Insights

ARCHIVES